Antidepressant treatment for acute bipolar depression: An update

Depression Research and Treatment

Volumn 2012, Issue , 2012, Pages

  Amit, Ben H ^a,b   Weizman, Abraham ^a,b  

^a GEHA MENTAL HEALTH CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84866257196     PISSN: 20901321     EISSN: 2090133X     Source Type: Journal    
DOI: 10.1155/2012/684725     Document Type: Review

References (69)

1. Judd L. L., Akiskal H. S., Schettler P. J., Endicott J., Leon A. C., Solomon D. A., Coryell W., Maser J. D., Keller M. B., Psychosocial disability in the course of bipolar I and II disorders: a prospective, comparative, longitudinal study. Archives of General Psychiatry 2005 62 12 1322 1330 2-s2.0-28544451011 10.1001/archpsyc.62.12.1322 (Pubitemid 41746610)
2. Murray C. J., Lopez A. D., Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. The Lancet 1997 349 9064 1498 1504 2-s2.0-0031001720 10.1016/S0140-6736(96)07492-2 (Pubitemid 27216360)
3. Tondo L., Isacsson G., Baldessarini R. J., Suicidal behaviour in bipolar disorder: risk and prevention. CNS Drugs 2003 17 7 491 511 2-s2.0-0038281515 10.2165/00023210-200317070-00003 (Pubitemid 36693704)
4. Pini S., de Queiroz V., Pagnin D., Pezawas L., Angst J., Cassano G. B., Wittchen H. U., Prevalence and burden of bipolar disorders in European countries. European Neuropsychopharmacology 2005 15 4 425 434 2-s2.0-19844362608 10.1016/j.euroneuro.2005.04.011 (Pubitemid 40943546)
5. Merikangas K. E., Akiskal H. S., Angst J., Greenberg P. E., Hirschfeld R. M. A., Petukhova M., Kessler R. C., Lifetime and 12-month prevalence of bipolar spectrum disorder in the national comorbidity survey replication. Archives of General Psychiatry 2007 64 5 543 552 2-s2.0-34247536530 10.1001/archpsyc.64.5. 543 (Pubitemid 46718287)
6. Judd L. L., Akiskal H. S., Schettler P. J., Endicott J., Maser J., Solomon D. A., Leon A. C., Rice J. A., Keller M. B., The long-term natural history of the weekly symptomatic status of bipolar I disorder. Archives of General Psychiatry 2002 59 6 530 537 2-s2.0-0036270011 (Pubitemid 34602935)
7. Kessler R. C., Akiskal H. S., Ames M., Birnbaum H., Greenberg P., Hirschfeld R. M., Jin R., Merikangas K. R., Simon G. E., Wang P. S., Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers. American Journal of Psychiatry 2006 163 9 1561 1568 2-s2.0-33749057523 10.1176/appi.ajp.163.9.1561 (Pubitemid 44465756)
8. Valtonen H. M., Suominen K., Haukka J., Mantere O., Leppämäki S., Arvilommi P., Isometsä E. T., Differences in incidence of suicide attempts during phases of bipolar I and II disorders. Bipolar Disorders 2008 10 5 588 596 2-s2.0-47549113501 10.1111/j.1399-5618.2007.00553.x (Pubitemid 352005790)
9. Altshuler L. L., Gitlin M. J., Mintz J., Leight K. L., Frye M. A., Subsyndromal depression is associated with functional impairment in patients with bipolar disorder. Journal of Clinical Psychiatry 2002 63 9 807 811 2-s2.0-0036737210
10. Perlis R. H., Ostacher M. J., Patel J. K., Marangell L. B., Zhang H., Wisniewski S. R., Ketter T. A., Miklowitz D. J., Otto M. W., Gyulai L., Reilly-Harrington N. A., Nierenberg A. A., Sachs G. S., Thase M. E., Predictors of recurrence in bipolar disorder: primary outcomes from the systematic treatment enhancement program for bipolar disorder (STEP-BD). American Journal of Psychiatry 2006 163 2 217 224 2-s2.0-33645004244 10.1176/appi.ajp.163.2.217 (Pubitemid 44480840)
11. Baldessarini R. J., Leahy L., Arcona S., Gause D., Zhang W., Hennen J., Patterns of psychotropic drug prescription for U.S. patients with diagnoses of bipolar disorders. Psychiatric Services 2007 58 1 85 91 2-s2.0-33847074549
12. Goldberg J. F., Truman C. J., Antidepressant-induced mania: an overview of current controversies. Bipolar Disorders 2003 5 6 407 420 2-s2.0-0346025644 10.1046/j.1399-5618.2003.00067.x (Pubitemid 38072243)
13. Amsterdam J. D., Shults J., Comparison of fluoxetine, olanzapine, and combined fluoxetine plus olanzapine initial therapy of bipolar type I and type II major depression-lack of manic induction. Journal of Affective Disorders 2005 87 1 121 130 2-s2.0-20444431812 10.1016/j.jad.2005.02.018 (Pubitemid 40828211)
14. McElroy S. L., Weisler R. H., Chang W., Olausson B., Paulsson B., Brecher M., Agambaram V., Merideth C., Nordenhem A., Young A. H., A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II). Journal of Clinical Psychiatry 2010 71 2 163 174 2-s2.0-77649138108 10.4088/JCP.08m04942gre
15. Amsterdam J. D., Shults J., Efficacy and mood conversion rate of short-term fluoxetine monotherapy of bipolar II major depressive episode. Journal of Clinical Psychopharmacology 2010 30 3 306 311 2-s2.0-77952409605 10.1097/JCP.0b013e3181da5300
16. Parker G., Tully L., Olley A., Hadzi-Pavlovic D., SSRIs as mood stabilizers for bipolar II disorder? a proof of concept study. Journal of Affective Disorders 2006 92 2-3 205 214 2-s2.0-33646413411 10.1016/j.jad.2006. 01.024
17. Amsterdam J. D., Shults J., Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study. Journal of Clinical Psychopharmacology 2008 28 2 171 181 2-s2.0-40949157179 10.1097/JCP.0b013e318166c4e6 (Pubitemid 351417122)
18. Amsterdam J. D., Wang C. H., Shwarz M., Shults J., Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial. Journal of Affective Disorders 2009 112 1-3 219 230 2-s2.0-56249121874 10.1016/j.jad.2008.03.029
19. Amsterdam J. D., Wang G., Shults J., Venlafaxine monotherapy in bipolar type II depressed patients unresponsive to prior lithium monotherapy. Acta Psychiatrica Scandinavica 2010 121 3 201 208 2-s2.0-76449086363 10.1111/j.1600-0447.2009.01462.x
20. Amsterdam J. D., Garcia-España F., Venlafaxine monotherapy in women with bipolar II and unipolar major depression. Journal of Affective Disorders 2000 59 3 225 229 2-s2.0-0034118594 10.1016/S0165-0327(99)00149-4 (Pubitemid 30347545)
21. Agosti V., Stewart J. W., Efficacy and safety of antidepressant monotherapy in the treatment of bipolar-II depression. International Clinical Psychopharmacology 2007 22 5 309 311 2-s2.0-34547811668 10.1097/YIC. 0b013e3280c28410 (Pubitemid 47237550)
22. Gijsman H. J., Geddes J. R., Rendell J. M., Nolen W. A., Goodwin G. M., Antidepressants for bipolar depression: a systematic review of randomized, controlled trials. American Journal of Psychiatry 2004 161 9 1537 1547 2-s2.0-4444339446 10.1176/appi.ajp.161.9.1537 (Pubitemid 39201448)
23. Goodwin G. M., Evidence-based guidelines for treating bipolar disorder: recommendations from the British association for psychopharmacology. Journal of Psychopharmacology 2003 17 2 149 173 2-s2.0-0038000594 10.1177/ 0269881103017002003 (Pubitemid 36753531)
24. American Psychiatric Association, Practice guideline for the treatment of patients with bipolar disorder (revision). American Journal of Psychiatry 2002 159 supplement 4 1 50
25. Fetter J. C., Askland K. D., Antidepressants for bipolar depression. The American Journal of Psychiatry 2005 162 8 1546 1568
26. Masand P., Mago R., Review: in people with bipolar disorder, short term antidepressants improve clinical response, although tricyclics risk inducingmania. Evidence-Based Mental Health 2005 8 2 35 10.1136/ebmh.8.2.35
27. Schaffer A., Zuker P., Levitt A., Randomized, double-blind pilot trial comparing lamotrigine versus citalopram for the treatment of bipolar depression. Journal of Affective Disorders 2006 96 1-2 95 99 2-s2.0-33749615989 10.1016/j.jad.2006.05.023 (Pubitemid 44548053)
28. Fonseca M., Soares J. C., Hatch J. P., Santin A. P., Kapczinski F., An open trial of adjunctive escitalopram in bipolar depression. Journal of Clinical Psychiatry 2006 67 1 81 86 2-s2.0-32244449256 (Pubitemid 43213286)
29. Sachs G. S., Nierenberg A. A., Calabrese J. R., Marangell L. B., Wisniewski S. R., Gyulai L., Friedman E. S., Bowden C. L., Fossey M. D., Ostacher M. J., Ketter T. A., Patel J., Hauser P., Rapport D., Martinez J. M., Allen M. H., Miklowitz D. J., Otto M. W., Dennehy E. B., Thase M. E., Effectiveness of adjunctive antidepressant treatment for bipolar depression. New England Journal of Medicine 2007 356 17 1711 1722 2-s2.0-34247476744 10.1056/NEJMoa064135 (Pubitemid 46658703)
30. Truman C. J., Goldberg J. F., Ghaemi S. N., Baldassano C. F., Wisniewski S. R., Dennehy E. B., Thase M. E., Sachs G. S., Self-reported history of manic/hypomanic switch associated with antidepressant use: data from the systematic treatment enhancement program for bipolar disorder (STEP-BD). Journal of Clinical Psychiatry 2007 68 10 1472 1479 2-s2.0-35948981808 (Pubitemid 350073393)
31. Altshulesr L. L., Suppes T., Black D. O., Nolen W. A., Leverich G., Keck P. E., Frye M. A., Kupka R., McElroy S. L., Grunze H., Kitchen C. M. R., Post R., Lower switch rate in depressed patients with bipolar II than bipolar I disorder treated adjunctively with second-generation antidepressants. American Journal of Psychiatry 2006 163 2 313 315 2-s2.0-33645007140 10.1176/appi.ajp. 163.2.313 (Pubitemid 44480853)
32. Sidor M. M., MacQueen G. M., Antidepressants for the acute treatment of bipolar depression: a systematic review and meta-analysis. Journal of Clinical Psychiatry 2011 72 2 156 167 10.4088/JCP.09r05385gre
33. Tohen M., Vieta E., Calabrese J., Ketter T. A., Sachs G., Bowden C., Mitchell P. B., Centorrino F., Risser R., Baker R. W., Evans A. R., Beymer K., Dubé S., Tollefson G. D., Breier A., Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Archives of General Psychiatry 2003 60 11 1079 1088 2-s2.0-10744220918 10.1001/archpsyc.60.11.1079 (Pubitemid 37429647)
34. Tohen M., Vieta E., Calabrese J., Ketter T. A., Sachs G., Bowden C., Mitchell P. B., Centorrino F., Risser R., Baker R. W., Evans A. R., Beymer K., Dubé S., Tollefson G. D., Breier A., Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Archives of General Psychiatry 2004 61 2 168 176
35. Shelton R. C., Stahl S. M., Risperidone and paroxetine given singly and in combination for bipolar depression. Journal of Clinical Psychiatry 2004 65 12 1715 1719 2-s2.0-13744264032 10.4088/JCP.v65n1218
36. Nemeroff C. B., Evans D. L., Gyulai L., Sachs G. S., Bowden C. L., Gergel I. P., Oakes R., Pitts C. D., Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression. American Journal of Psychiatry 2001 158 6 906 912 2-s2.0-0034976168 10.1176/appi.ajp.158. 6.906 (Pubitemid 32547620)
37. Cohn J. B., Collins G., Ashbrook E., Wernicke J. F., A comparison of fluoxetine imipramine and placebo in patients with bipolar depressive disorder. International Clinical Psychopharmacology 1989 4 4 313 322 2-s2.0-0024741177
38. Himmelhoch J. M., Fuchs C. Z., Symons B. J., A double-blind study of tranylcypromine treatment of major anergic depression. Journal of Nervous and Mental Disease 1982 170 10 628 634 2-s2.0-0019957843 (Pubitemid 12036008)
39. Mendlewicz J., Youdim M. B., Antidepressant potentiation of 5-hydroxytryptophan by L-deprenil in affective illness. Journal of Affective Disorders 1980 2 2 137 146 2-s2.0-0018872281 10.1016/0165-0327(80)90013-0 (Pubitemid 10117157)
40. Post R. M., Altshuler L. L., Leverich G. S., Frye M. A., Nolen W. A., Kupka R. W., Suppes T., McElroy S., Denicoff K. D., Grunze H., Kitchen C. M. R., Mintz J., Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline. British Journal of Psychiatry 2006 189 124 131 2-s2.0-33747186481 10.1192/bjp.bp.105.013045 (Pubitemid 44231270)
41. Pilhatsch M., Wolf R., Winter C., Lewitzka U., Bauer M., Comparison of paroxetine and amitriptyline as adjunct to lithium maintenance therapy in bipolar depression: a reanalysis of a randomized, double-blind study. Journal of Affective Disorders 2010 126 3 453 457 2-s2.0-77957349180 10.1016/j.jad.2010. 04.025
42. van der Loos M. L., Mulder P., Hartong E. G., Blom M. B., Vergouwen A. C., Van Noorden M. S., Timmermans M. A., Vieta E., Nolen W. A., Efficacy and safety of two treatment algorithms in bipolar depression consisting of a combination of lithium, lamotrigine or placebo and paroxetine. Acta Psychiatrica Scandinavica 2010 122 3 246 254 2-s2.0-77955004373 10.1111/j.1600-0447.2009. 01537.x
43. U.S Department of Health & Human Services, U.S Food & Drug Administration,. Symbyax Product Label #NDA21-520
44. Shi L., Namjoshi M. A., Swindle R., Yu X., Risser R., Baker R. W., Tohen M., Effects of olanzapine alone and olanzapine/fluoxetine combination on health-related quality of life in patients with bipolar depression: secondary analyses of a double-blind, placebo-controlled, randomized clinical trial. Clinical Therapeutics 2004 26 1 125 134 2-s2.0-1242317086 10.1016/S0149-2918(04) 90013-6 (Pubitemid 38241530)
45. Perlis R. H., Adams D. H., Fijal B., Sutton V. K., Farmen M., Breier A., Houston J. P., Genetic association study of treatment response with olanzapine/fluoxetine combination or lamotrigine in bipolar I depression. Journal of Clinical Psychiatry 2010 71 5 599 605 2-s2.0-77952626856 10.4088/JCP.08m04632gre
46. Tamayo J. M., Sutton V. K., Mattei M. A., Diaz B., Jamal H. H., Vieta E., Zarate C. A. Jr, Fumero I., Tohen M., Effectiveness and safety of the combination of fluoxetine and olanzapine in outpatients with bipolar depression: an open-label, randomized, flexible-dose study in puerto rico. Journal of Clinical Psychopharmacology 2009 29 4 358 361 2-s2.0-68449101173 10.1097/JCP.0b013e3181ad223f
47. Hantouche E. G., Akiskal H. S., Bipolar II vs. unipolar depression: psychopathologic differentiation by dimensional measures. Journal of Affective Disorders 2005 84 2-3 127 132 2-s2.0-13544259655 10.1016/j.jad.2004.01.017 (Pubitemid 40222493)
48. Correa R., Akiskal H., Gilmer W., Nierenberg A. A., Trivedi M., Zisook S., Is unrecognized bipolar disorder a frequent contributor to apparent treatment resistant depression? Journal of Affective Disorders 2010 127 1-3 10 18 2-s2.0-78149360952 10.1016/j.jad.2010.06.036
49. Benazzi F., Akiskal H., The duration of hypomania in bipolar-II disorder in private practice: methodology and validation. Journal of Affective Disorders 2006 96 3 189 196 2-s2.0-33845628785 10.1016/j.jad.2004.04.006 (Pubitemid 44827272)
50. Berk M., Brnabic A., Dodd S., Kelin K., Tohen M., Malhi G. S., Berk L., Conus P., McGorry P. D., Does stage of illness impact treatment response in bipolar disorder? empirical treatment data and their implication for the staging model and early intervention. Bipolar Disorders 2011 13 1 87 98 10.1111/j.1399-5618.2011.00889.x
51. Arvilommi P., Suominen K. S., Mantere O. K., Leppämäki S., Valtonen H., Isometsä E. T., Adequacy of treatment received by diagnosed and undiagnosed patients with bipolar I and II disorders. Journal of Clinical Psychiatry 2007 68 1 102 110 2-s2.0-33846865552 (Pubitemid 46220131)
52. Berk M., Hallam K., Malhi G. S., Henry L., Hasty M., MacNeil C., Yucel M., Pantelis C., Murphy B., Vieta E., Dodd S., McGorry P. D., Evidence and implications for early intervention in bipolar disorder. Journal of Mental Health 2010 19 2 113 126 2-s2.0-77950801509 10.3109/09638230903469111
53. Matza L. S., Rajagopalan K. S., Thompson C. L., de Lissovoy G., Misdiagnosed patients with bipolar disorder: comorbidities, treatment patterns, and direct treatment costs. Journal of Clinical Psychiatry 2005 66 11 1432 1440 2-s2.0-28844451146 (Pubitemid 41779542)
54. McCombs J. S., Ahn J., Tencer T., Shi L., The impact of unrecognized bipolar disorders among patients treated for depression with antidepressants in the fee-for-services California Medicaid (Medi-Cal) program: a 6-year retrospective analysis. Journal of Affective Disorders 2007 97 1-3 171 179 2-s2.0-33845629053 10.1016/j.jad.2006.06.018 (Pubitemid 44940824)
55. Mendlewicz J., Massat I., Linotte S., Kasper S., Konstantinidis A., Lecrubier Y., Montgomery S., Serretti A., Zohar J., Souery D., Identification of clinical factors associated with resistance to antidepressants in bipolar depression: results from an European multicentre study. International Clinical Psychopharmacology 2010 25 5 297 301 2-s2.0-77955467628 10.1097/YIC. 0b013e32833c4ceb
56. Baca-Garcia E., Sher L., Perez-Rodriguez M. M., Burke A. K., Sullivan G. M., Grunebaum M. F., Stanley B. H., Mann J. J., Oquendo M. A., Treatment of depressed bipolar patients with alcohol use disorders: plenty of room for improvement. Journal of Affective Disorders 2009 115 1-2 262 268 2-s2.0-62649145531 10.1016/j.jad.2008.09.012
57. Ostacher M. J., Perlis R. H., Nierenberg A. A., Calabrese J., Stange J. P., Salloum I., Weiss R. D., Sachs G. S., Impact of substance use disorders on recovery from episodes of depression in bipolar disorder patients: prospective data from the systematic treatment enhancement program for bipolar disorder (STEP-BD). American Journal of Psychiatry 2010 167 3 289 297 2-s2.0-77649156797 10.1176/appi.ajp.2009.09020299
58. Kemp D. E., Ganocy S. J., Brecher M., Carlson B. X., Edwards S., Eudicone J. M., Evoniuk G., Jansen W., Leon A. C., Minkwitz M., Pikalov A., Stassen H. H., Szegedi A., Tohen M., Van Willigenburg A. P. P., Calabrese J. R., Clinical value of early partial symptomatic improvement in the prediction of response and remission during short-term treatment trials in 3369 subjects with bipolar I or II depression. Journal of Affective Disorders 2010 130 1-2 171 179 2-s2.0-78049472403 10.1016/j.jad.2010.10.026
59. Busby K. K., Sajatovic M., Patient, treatment, and systems-level factors in bipolar disorder nonadherence: a summary of the literature. CNS Neuroscience and Therapeutics 2010 16 5 308 315 2-s2.0-77956407739 10.1111/j.1755-5949.2010. 00191.x
60. Ghaemi S. N., Ostacher M. M., El-Mallakh R. S., Borrelli D., Baldassano C. F., Kelley M. E., Filkowski M. M., Hennen J., Sachs G. S., Goodwin F. K., Baldessarini R. J., Antidepressant discontinuation in bipolar depression: a systematic treatment enhancement program for bipolar disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety. Journal of Clinical Psychiatry 2010 71 4 372 380 2-s2.0-77951058041 10.4088/JCP.08m04909gre
61. Altshuler L. L., Post R. M., Hellemann G., Leverich G. S., Nolen W. A., Frye M. A., Keck P. E. Jr, Kupka R. W., Grunze H., McElroy S. L., Sugar C. A., Suppes T., Impact of antidepressant continuation after acute positive or partial treatment response for bipolar depression: a blinded, randomized study. Journal of Clinical Psychiatry 2009 70 4 450 457 2-s2.0-66349085041 10.4088/JCP.08m04191
62. Joffe R. T., MacQueen G. M., Marriott M., Young L. T., One-year outcome with antidepressant-treatment of bipolar depression. Acta Psychiatrica Scandinavica 2005 112 2 105 109 2-s2.0-22344450808 10.1111/j.1600-0447.2005. 00583.x (Pubitemid 41003188)
63. Marangell L. B., Dennehy E. B., Miyahara S., Wisniewski S. R., Bauer M. S., Rapaport M. H., Allen M. H., The functional impact of subsyndromal depressive symptoms in bipolar disorder: data from STEP-BD. Journal of Affective Disorders 2009 114 1-3 58 67 2-s2.0-59649129159 10.1016/j.jad.2008.07.006
64. American Psychiatric Association (APA), Practice Guideline for the Treatment of Patients with Bipolar Disorder 2005 2nd Arlington, Va, USA American Psychiatric Association
65. Kasper S., Calabrese J. R., Johnson G., Tajima O., Vieta E., Viguera A. C., Yatham L. N., Young A. H., International consensus group on the evidence-based pharmacologic treatment of bipolar I and II depression. Journal of Clinical Psychiatry 2008 69 10 1632 1646 2-s2.0-54949139986
66. National Institute for Health and Clinical Excellence (NICE), Clinical Guidelines: The Management of Bipolar Disorder in Adults, Children and Adolescents, in Primary and Secondary Care 2009 London, UK National Institute for Health and Clinical Excellence
67. Yatham L. N., Kennedy S. H., Schaffer A., Parikh S. V., Beaulieu S., O'Donovan C., MacQueen G., McIntyre R. S., Sharma V., Ravindran A., Young L. T., Young A. H., Alda M., Milev R., Vieta E., Calabrese J. R., Berk M., Ha K., Kapczinski F., Canadian network for mood and anxiety treatments (CANMAT) and international society for bipolar disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disorders 2009 11 3 225 255 2-s2.0-65249143218 10.1111/j.1399-5618.2009.00672.x
68. Goodwin G. M., Evidence-based guidelines for treating bipolar disorder: revised second edition-recommendations from the British association for psychopharmacology. Journal of Psychopharmacology 2009 23 4 346 388 2-s2.0-65649095161 10.1177/0269881109102919
69. Grunze H., Vieta E., Goodwin G. M., Bowden C., Licht R. W., Mller H. J., Kasper S., The world federation of societies of biological psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2010 on the treatment of acute bipolar depression. World Journal of Biological Psychiatry 2010 11 2 81 109 2-s2.0-77649207564 10.3109/15622970903555881